NCT05994885

Brief Summary

Ability to anticipate the outcomes of periodontal therapy at baseline visit is crucial to outline and customize a treatment plan with predictable outcomes and cost-effectiveness. Presence of diverse range of health/disease-associated molecules in oral environment that reflect health and disease, together with clinical parameters, is an appealing approach to use them as biomarkers to diagnose, predict, and monitor periodontal disease. Among these proteins are E-cad and TAC which available evidence indicate that their concentrations in oral biofluids increase remarkably during periodontitis as compared to healthy periodontium.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 15, 2023

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

August 9, 2023

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 16, 2023

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2023

Completed
10 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 25, 2023

Completed
Last Updated

August 16, 2023

Status Verified

August 1, 2023

Enrollment Period

10 months

First QC Date

August 9, 2023

Last Update Submit

August 9, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Probing pocket depth

    Linear distance, in mm, measured from the gingival margin to the base of periodontal pocket or sulcus.

    Baseline, 1 week, then 1 month and 3 months after treatment

Secondary Outcomes (4)

  • Clinical attachment loss

    Baseline, 1 week, then 1 month and 3 months after treatment

  • Bleeding on probing

    Baseline, 1 week, then 1 month and 3 months after treatment

  • Gingival crevicular fluid E-cadherin

    Baseline, 1 month and 3 months after treatment

  • Total antioxidant capacity

    Baseline, 1 month and 3 months after treatment

Study Arms (1)

Root surface debridement

OTHER

Periodontal pockets with PPD of 4 to 6mm are treated with root surface debridement only and assessed after 3 months for success/failure of treatment.

Procedure: Root surface debridement

Interventions

the included patients will undergo full-mouth supra- and subgingival debridement by using ultrasonic device and manual instrumentation at baseline. This is followed, after 1 week, by performing root surface debridement for all pockets with PPD = 4-6 mm for each patient. All patients will be instructed to brush their teeth twice daily and will be supplied with the same type of tooth paste and toothbrush, with suitable interdental aids.

Root surface debridement

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Systemically healthy adult patients (\> 18 years).
  • Periodontitis (interdental clinical attachment loss (CAL) detectable at ≥2 non-adjacent teeth, or buccal/oral CAL of ≥3mm with pocketing of \>3mm is detectable at ≥2 teeth). All patients should exhibit generalized periodontitis with pockets of PPD = 4 to 6 mm of any stage, unstable, and grade A to C. Only maxillary teeth with single root will be included.

You may not qualify if:

  • Consumption of antibiotics or periodontal treatment 3-months prior to the study.
  • Pregnancy and lactation.
  • Smoker.
  • History of systemic disease e.g., diabetes mellitus.
  • Patients currently recruited in other trials.
  • Patients not willing to consent.
  • Periodontal pockets ≥ 7mm, active caries, endodontic problem.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

College of Dentistry/ University of Baghdad

Baghdad, Iraq

RECRUITING

MeSH Terms

Conditions

Periodontitis

Condition Hierarchy (Ancestors)

Periodontal DiseasesMouth DiseasesStomatognathic Diseases

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Masking Details
The care provider is not aware about clinical parameters and biochemical analysis of GCF (E-cadherin and total antioxidant capacity).
Purpose
OTHER
Intervention Model
SINGLE GROUP
Model Details: Patients with periodontitis, of any stage, having periodontal pockets of a moderate depth (4 to 6 mm) treated with nonsurgical periodontal therapy.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

August 9, 2023

First Posted

August 16, 2023

Study Start

February 15, 2023

Primary Completion

December 15, 2023

Study Completion

December 25, 2023

Last Updated

August 16, 2023

Record last verified: 2023-08

Data Sharing

IPD Sharing
Will not share

Locations